Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

American Pain Association (APA) Commends President Trump’s Recent Actions to Stem America’s Opioid Epidemic
  • USA - English


News provided by

CMW Media

Apr 10, 2017, 14:55 ET

Share this article

Share toX

Share this article

Share toX


(PRWEB) April 10, 2017 -- American Pain Association ( APA) today announced that it commends President Trump for signing an executive order that will create a Commission on Combating Drug Addiction and the Opioid Crisis to cope with the roughly 2.5 million Americans addicted to opioids.

The opioid epidemic in continues to escalate and simply increasing funding is not the answer. If we are to win this war against this epidemic, we need to have a central command with ongoing watch and action by a multidisciplinary, inter-agency task force.

Post this

While the United States makes up less than 5 percent of the world’s total population, it contributes to 75 percent of the world’s opioid prescription drugs, with drug doses as the most common cause of unintentional death with the Country. Of the 20.5 million Americans that had a substance use disorder in 2015, 2 million had a substance use disorder involving prescription pain relievers.

“As a community, we haven’t been skeptical enough of what these medications could do for too long and haven’t asked enough questions,” said Dr. Sanjay Gupta, President of the APA. “We accepted flimsy scientific data promoted by pharmaceutical companies as gospel and preached it to our patients in a chamber that echoed loudly for decades. There are a number of factors that have created this perfect storm of dependency and overdose in the United States, including the poser of insurance companies to dictate the medical approach, because on the surface pills are a much cheaper option than a multidisciplinary approach, which has caused the death of millions of our citizens. With more then 250 million narcotic prescriptions written in America every year, drug manufacturers can certainly do more to curb this deadly epidemic ".

The APA also commends President Trump for appointing New Jersey Governor Chris Christie to run the commission, who will work to “combat and treat the scourge of drug abuse, addiction, and the opioid crisis,” the White House said in a statement. The APA believes Governor Christie is an outspoken advocate for a public-health approach to opioid addiction with a proven, action-oriented record in his state of New Jersey, including his recent signing of a sweeping piece of anti-addiction legislation that mandates insurance coverage for up to six months of substance abuse treatment, imposes the nation’s strongest limit on initial opioid drug prescriptions and requires education for patients and doctors about the risks associated with the drugs.

“President Trump’s recent initiative to set up a Commission to work on this issue is a step in the right direction for combating our nation’s escalating opioid crisis,” said Dr. Gupta. “The opioid epidemic in this continues to escalate and simply increasing funding is not the answer. If we are to win this war against this epidemic, we need to have a central command with ongoing watch and action by a multidisciplinary, inter-agency task force.”

Despite billions of dollars in increased funding to fight the nation’s opioid epidemic, drug overdose deaths and opioid-involved deaths continue to increase in the United States and “the worst is yet to come,” a drug court judge said during a panel at the 2017 AAAS Science & Technology Policy Forum, which was held March 27-28 in Washington.

From 2000 to 2015, more than 500,000 people died from drug overdoses, according to the U.S. Centers for Disease Control and Prevention (CDC) with the majority of drug overdose deaths (more than six out of ten) involving an opioid. In fact, 91 Americans die every day from an opioid overdose.

“Addiction and opioid abuse is killing more people than guns, road accidents and any terrorist attack, disaster or war that America has ever faced and that is just the tip of the iceberg,” added Dr. Gupta. “Nonetheless, the issue seemed to have been pushed under the rug in the past with the U.S. Surgeon General in 2015 choosing “Walking for Fitness” as his “Call to Action” plan, rather than this insidious pill epidemic. Therefore, we are hopeful that President Trump’s improved federal response to addiction and the opioid crisis, with his Commission and new appointments, that we are able to begin reversing this epidemic that is claiming the lives of Americans and costing health insurers and taxpayers trillions of dollars.”

Dr. Gupta believes Trump’s nominee to head the Food and Drug Administration Dr. Scott Gottlieb, who said the he would “push the policy boundaries” for approval of safer opioids and other alternatives if he is confirmed, is also the right choice for the nation in terms of policy moving forward for the opioid crisis. Dr. Gottlieb said opioid addiction is “the biggest crisis facing the agency and tackling it would be his first priority, requiring “dramatic action,” including ways to spur development of non-addictive alternative pain killers, as well as addiction treatments.

In 2016, Dr. Gupta and the APA launched a national opioid awareness initiative focused on educating the public on the dangers of opioids and prescription opioid addiction, plus requested that the U.S. Surgeon General add the U.S. opioid epidemic to the nation’s “Call to Action.” The APA also received more than 12,000 online signatures from the public on a petition to aid their request.

In addition, the APA recommends a plan of action that includes dedicating efforts and resources towards improving the science of pain management and inclusion of pain specialists in policy developments. CDC Opioid Guideline development panel last year did not include any pain specialist.

About the American Pain Association:
The primary efforts of American Pain Association are directed towards education, research and improving treatment. We are also working in the area of developing expert consensus statements regarding pain issues. If you wish to participate in our activities or gather more information, please feel free to contact us at [email protected]. Membership is open to all people from all walks of life, who are interested in Pain Management. For more information, visit http://www.painassociation.org

Contact information

Public Relations contact:
Andrew Hard
CEO
CMW Media
P. 888-829-0070
Andrew.Hard(at)cmwmedia(dot)com
http://www.cmwmedia.com

Corporate contact:
Dr. Sanjay Gupta
610-664-3000
President
American Pain Association

Aaron Wood, CMW Media, +1 4136272468, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.